Bosentan reduces the number of new digital ulcers in patients with systemic sclerosis open label extension to a double-blind trialCasilda G. Black, Korn Jh, CP Denton et al.|UCL Discovery (University College London)|2006Cited by 6
Autoantibody profile rather than extent of skin disease predicts severity of pulmonary fibrosis in systemic sclerosisRK Hoyles, Adrian Wells, Casilda G. Black et al.|UCL Discovery (University College London)|2006Cited by 1
Bosentan for scleroderma associated pulmonary arterial hypertension - A subgroup analysis of two placebo controlled trials.CP Denton, Casilda G. Black|UCL Discovery (University College London)|2003Cited by 1
Evaluation of CCL2 as a potential biomarker of pulmonary vascular disease in limited cutaneous systemic sclerosisM. T. Carulli, CP Denton, Dietmar Abraham et al.|UCL Discovery (University College London)|2004Cited by 1
A STUDY OF SEXUAL DYSFUNCTION AMONGST MEN WITH SYSTEMIC SCLEROSIS IN THE UK: PREVALENCE AND PSYCHOLOGICAL IMPACTTanaka Ngcozana, Duu Sheng Ong, CP Denton et al.|UCL Discovery (University College London)|2011Cited by 0